Ayako Mitsuma

730 total citations
43 papers, 532 citations indexed

About

Ayako Mitsuma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ayako Mitsuma has authored 43 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ayako Mitsuma's work include Cancer Treatment and Pharmacology (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ayako Mitsuma is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Ayako Mitsuma collaborates with scholars based in Japan, United States and Germany. Ayako Mitsuma's co-authors include Yukio Ando, Sachi Morita, Masataka Sawaki, Tomoya Shimokata, Takashi Shibata, Tomoyo Oguri, Keisuke Uehara, Toshihiko Doi, Masahiko Sato and Atsushi Ohtsu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Ayako Mitsuma

40 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayako Mitsuma Japan 13 294 189 122 63 59 43 532
Shunji Miki Japan 9 231 0.8× 189 1.0× 91 0.7× 53 0.8× 82 1.4× 15 651
Yasushi Otani Japan 10 383 1.3× 149 0.8× 171 1.4× 32 0.5× 14 0.2× 19 607
Nathan D. Seligson United States 13 213 0.7× 192 1.0× 165 1.4× 22 0.3× 44 0.7× 38 532
Lavina Bharwani Singapore 9 491 1.7× 356 1.9× 179 1.5× 61 1.0× 35 0.6× 13 861
Katrin Friedbichler Austria 9 158 0.5× 187 1.0× 39 0.3× 45 0.7× 38 0.6× 13 412
Lei Deng China 12 330 1.1× 219 1.2× 71 0.6× 19 0.3× 70 1.2× 25 786
Bruce Keith United States 10 243 0.8× 121 0.6× 262 2.1× 29 0.5× 20 0.3× 15 504
Susan M. Flick United States 6 132 0.4× 113 0.6× 72 0.6× 58 0.9× 21 0.4× 6 370
Annalisa Savonarola Italy 16 238 0.8× 238 1.3× 98 0.8× 57 0.9× 42 0.7× 20 550
Oliver J. Stoetzer Germany 14 206 0.7× 256 1.4× 97 0.8× 60 1.0× 51 0.9× 29 625

Countries citing papers authored by Ayako Mitsuma

Since Specialization
Citations

This map shows the geographic impact of Ayako Mitsuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Mitsuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Mitsuma more than expected).

Fields of papers citing papers by Ayako Mitsuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Mitsuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Mitsuma. The network helps show where Ayako Mitsuma may publish in the future.

Co-authorship network of co-authors of Ayako Mitsuma

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Mitsuma. A scholar is included among the top collaborators of Ayako Mitsuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Mitsuma. Ayako Mitsuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tahara, Makoto, Hiroshi Takami, Yasuhiro Ito, et al.. (2024). A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer. Thyroid. 34(5). 566–574. 9 indexed citations
2.
Takano, Yuko, Sachi Morita, Megumi Inoue, et al.. (2021). P44-9 A case of recurrent gastric cancer with drug-induced immune thrombocytopenia caused by trastuzumab. Annals of Oncology. 32. S354–S354.
3.
Kondo, Chiaki, Yuko Takano, Tomoya Shimokata, et al.. (2021). Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment. International Cancer Conference Journal. 11(1). 46–48. 3 indexed citations
4.
Minami, Hironobu, Toshihiko Doi, Masanori Toyoda, et al.. (2020). Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies. Cancer Science. 112(2). 725–733. 6 indexed citations
5.
Maeda, Osamu, Yukihiro Yokoyama, Junpei Yamaguchi, et al.. (2017). Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan. Annals of Oncology. 28. x69–x69. 5 indexed citations
6.
Kanda, Kiyoko, et al.. (2017). Salient features and outline of the joint Japanese guidelines for safe handling of cancer chemotherapy drugs. Asia-Pacific Journal of Oncology Nursing. 4(4). 304–312. 4 indexed citations
7.
Honda, Kazunori, Kyosuke Takeshita, Kenta Murotani, et al.. (2016). Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer. Breast Cancer. 24(2). 312–318. 7 indexed citations
8.
Yamamoto, Eiko, Kaoru Niimi, Tetsuya Nishida, et al.. (2016). High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review. Molecular and Clinical Oncology. 5(5). 660–664. 12 indexed citations
9.
Morita, Sachi, Mariko Hiramatsu, Bishal Gyawali, et al.. (2015). Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case report. Oncology Letters. 10(2). 972–974. 13 indexed citations
10.
Mukai, Hirofumi, Norikazu Masuda, Hiroshi Ishiguro, et al.. (2015). Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer. Cancer Chemotherapy and Pharmacology. 76(4). 739–750. 11 indexed citations
11.
Ando, Yukio, Kenji Kawada, Ayako Mitsuma, et al.. (2014). Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors. Cancer Chemotherapy and Pharmacology. 73(4). 673–683. 17 indexed citations
12.
Oguri, Tomoyo, Ayako Mitsuma, Sachi Morita, et al.. (2013). Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 475–481. 32 indexed citations
13.
Urakawa, Hiroshi, Ayako Mitsuma, Tomoya Shimokata, et al.. (2013). Effects of Zoledronic Acid on Renal Function in Patients with Malignant Tumor. Annals of Oncology. 24. ix73–ix73. 5 indexed citations
14.
Fujiwara, Yutaka, Yukio Ando, Toru Mukohara, et al.. (2013). A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(4). 991–998. 5 indexed citations
15.
Mitsuma, Ayako & Yukio Ando. (2013). Genetic backgrounds of peripheral neuropathy induced by oxaliplatin. Folia Pharmacologica Japonica. 141(2). 62–65. 1 indexed citations
16.
Ando, Yukio, Kenji Kawada, Sachi Morita, et al.. (2012). Pharmacokinetic Study of S-1 in Patients in Whom Inulin Clearance Was Measured. Oncology. 83(1). 38–44. 5 indexed citations
17.
Sato, M., Sachi Morita, Kakuya Kitagawa, et al.. (2010). Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes. International Journal of Clinical Pharmacology and Therapeutics. 48(11). 729–734. 51 indexed citations
18.
Kamei, Shinji, Ayako Mitsuma, Masataka Sawaki, et al.. (2010). The Feasibility Study of Docetaxel in Patients with Anaplastic Thyroid Cancer. Japanese Journal of Clinical Oncology. 40(6). 596–599. 41 indexed citations
19.
Mitsuma, Ayako, Haruhiko Asano, Tomohiro Kinoshita, et al.. (2005). Transcriptional regulation of FKLF-2 (KLF13) gene in erythroid cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1727(2). 125–133. 7 indexed citations
20.
Hirabayashi, N, et al.. (1998). Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia. Bone Marrow Transplantation. 21(11). 1079–1083. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunji Miki Breakdown of academic impact, for papers by Yasushi Otani Breakdown of academic impact, for papers by Nathan D. Seligson Breakdown of academic impact, for papers by Lavina Bharwani Breakdown of academic impact, for papers by Katrin Friedbichler Breakdown of academic impact, for papers by Lei Deng Breakdown of academic impact, for papers by Bruce Keith Breakdown of academic impact, for papers by Susan M. Flick Breakdown of academic impact, for papers by Annalisa Savonarola Breakdown of academic impact, for papers by Oliver J. Stoetzer
Rankless by CCL
2026